Skip to content

Search

Search managers or tickers

ValueAct Capital

Q1 2018 13F · by Mason Morfit, CIO

As of
Mar 31, 2018
Filed
May 15, 2018
US stock
$10.0B · prev $9.9B
Positions
12 · prev 13
Options notional
$0
Documents
1· no amendments

Picture100.0% US stock

Full picture · of what this 13F reports is US stock

  • US stock listed on a US exchange 100.0%
  • Foreign stock not listed in the US 0.0%
  • Notes debt, at principal 0.0%
  • Puts at notional value 0.0%
  • Calls at notional value 0.0%

Moves9 since the prior filing

The book

Very concentrated · behaves like 9 equal-sized positions

  1. Very concentrated
  2. Concentrated
  3. Focused
  4. Diversified

Moderate turnover · 49% a year, about 2.0 years per position

  1. Low
  2. Moderate
  3. High

Top 5 positions66% of US stock

  1. unresolved Twenty First Centy Fox Inc held held19.4%
  2. STXN Seagate Technology Holdings PLC (Ireland) held held12.6%
  3. BFH Bread Financial Holdings, Inc. held held12.5%
  4. C Citigroup Inc. added+10.13 pp added+10.1311.0%
  5. unresolved Kkr & Co L P DEL added−0.07 pp added−0.0710.1%

Positions12 in this filing · 2 exited

unresolvedTwenty First Centy Fox Inc19.44%53,326,334$1.9Bheld—16 q
STXNSeagate Technology Holdings PLC (Ireland)12.59%21,458,600$1.3Bheld—8 q
BFHBread Financial Holdings, Inc.12.54%5,877,400$1.3Bheld—9 q
CCitigroup Inc.10.96%16,200,000$1.1Badded×14.7+10.13 pp2 q
unresolvedKkr & Co L P DEL10.11%49,700,000$1.0Badded+4%−0.07 pp4 q
MSMorgan Stanley9.72%17,959,620$969Mheld—8 q
CBRECbre Group, Inc.9.43%19,916,923$940Mtrimmed−20%−1.49 pp20 q
TRNTrinity Industries, Inc.7.00%21,407,891$699Madded+15%−0.05 pp8 q
AWIArmstrong World Industries, Inc.3.87%6,852,612$386Mtrimmed−26%−1.77 pp16 q
unresolvedValeant Pharmaceuticals Intl2.87%18,011,537$287Madded0%−0.92 pp20 q
SLMSLM Corporation0.83%7,400,000$83Mnew+0.83 ppnew
AFIIQArmstrong Flooring Inc0.63%4,609,071$63Mheld—8 q
MSFTMicrosoft Corp—−9,014,063—exited−7.80 pp—
unresolvedExpress Scripts Hldg Co—−1,200,000—exited−0.91 pp—

Source

Form
13F-HR
Reading
0 defects · 3 unresolved
Options
none in this filing
Notes
none in this filing
SEC cross-check
SEC data set not published yet